Altamira Therapeutics Ltd.(CYTO)
0.3000+0.00000.00%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Altamira Therapeutics Ltd.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Altamira Therapeutics Ltd.成立于1998年。该公司的目标是成为一家领先的生物医药公司，专注于开发和商业化RNA递送技术。该公司认为，使用RNA疗法,无论是siRNA、mRNA还是其他类型来控制疾病相关基因的表达，前景广阔。通过利用小分子和蛋白质在其他方面“无法药效”的靶点，有望开辟治疗疑难杂症的RNA疗法的全新途径。- 2024-11-14Form SC 13G - Statement of Beneficial Ownership by Certain Investors超过5%披露Form SC 13G - Statement of Beneficial Ownership by Certain Investors
- 2024-09-17Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2024-09-17Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2024-09-16Form F-1/A - Registration statement for certain foreign private issuers: [Amend][修订]招股说明书Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-09-16Form F-1/A - Registration statement for certain foreign private issuers: [Amend][修订]招股说明书Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-08-22Form F-1 - Registration statement for certain foreign private issuers招股说明书Form F-1 - Registration statement for certain foreign private issuers
- 2024-07-01Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend][修订]年度报告Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2024-04-22Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend][修订]年度报告Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2024-04-17Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2024-04-10Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2024-04-10Form F-1 - Registration statement for certain foreign private issuers招股说明书Form F-1 - Registration statement for certain foreign private issuers
- 2024-04-10Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]年度报告Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-03-13Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]超过5%披露Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2024-01-17Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2023-07-05Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
0.3000
今开
0.3000
量比
0.00
最低
0.3000
昨收
0.3000
换手率
0.00%